Clinical Trial: A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

Brief Summary: This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.

Detailed Summary:
Sponsor: Walter Reed Army Institute of Research (WRAIR)

Current Primary Outcome: Difference in degree of hemolysis of G6PD(-) red blood cells in treated vs untreated matched samples.

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Walter Reed Army Institute of Research (WRAIR)

Dates:
Date Received: January 20, 2004
Date Started: December 2003
Date Completion:
Last Updated: July 26, 2010
Last Verified: July 2010